Skip to search formSkip to main contentSkip to account menu

cefroxadine

Known as: 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((amino-1,4-cyclohexadien-1-ylacetyl)amino)-3-methoxy-8-oxo-, (6R-(6 alpha,7 beta(R*)))-, 7-(D-2-amino-2-(1,4-cyclohexadienyl)acetamido)-3-methoxy-3-cephem-4-carboxylic acid, cefroxadin 
A semisynthetic first-generation cephalosporin with antibacterial activity. Cefroxadine binds to and inactivates penicillin-binding proteins (PBPs… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Objective: To investigate the effect of the three aminocephalosporin antibiotics, cefroxadine, cefatrizine, and cephaloglycin on… 
1986
1986
Influence of cefroxadine (CXD) dry syrup on intestinal bacterial flora was studied in mice infected with 4 species of bacteria… 
1983
1983
The pharmacokinetics and bioavailability of cefroxadine were studied in 15 patients with different renal functions after… 
1983
1983
A double-blind controlled trial of cefroxadine (CXD) 250 mg t.i.d. was undertaken to objectively evaluate its safety and… 
1983
1983
To evaluate the efficacy, safety, and utility of cefroxadine (CXD) for the treatment of complicated urinary tract infections, a… 
1982
1982
It was shown that the intestinal absorption clearance of D2O (CLD2O) could be a more appropriate index to study the solvent drag… 
1981
1981
The pharmacokinetics of cefroxadine, a new orally active broad-spectrum cephalosporin, was studied in healthy volunteers and… 
1981
1981
The authors have carried out the laboratory and clinical studies of cefroxadine (CXD), and obtained the following results. The… 
1981
1981
A method employing high pressure liquid chromatography has been developed for the new cephalosporin cefroxadine (CGP 9000). This… 
1980
1980
Oral doses of 125, 250, and 500 mg of a new cephalosporin, CGP 9000 (7 beta-[D-2-amino-2-(1,4-cyclohexadienyl)-acetamido]-3…